费布里病心肌病:心脏病学家的实用指南
Tala Al Saleh1, Yusuf Kamran Qadeer2, Bing Yue3
1Department of Internal Medicine, Henry Ford Hospital, Detroit, MI; HumanX, Delaware, DE, USA.
Current problems in cardiology
|January 16, 2026
概括
法布里病 (FD) 是一种罕见的遗传性疾病,会导致有害的葡萄糖脂积累. 通过先进的成像技术进行早期检测有助于及时治疗,改善受影响个人和家庭的结果.
科学领域:
- 遗传学 是一个遗传学.
- 生物化学 生物化学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 费布里病 (FD) 是一种X链 lysosomal储存障碍.
- 它涉及到细胞中的葡萄糖脂积累,主要是globotriaosylceramide (Gb3).
- 心脏,神经和脏组织受到影响最大,心脏病是导致死亡的主要原因.
研究的目的:
- 为了突出Fabry病的诊断挑战.
- 强调先进成像在早期检测中的作用.
- 讨论对治疗启动和家庭查的影响.
主要方法:
- 复习法布里病的病理生理学和临床表现.
- 讨论诊断方面的进展,重点是心声回声和MRI.
- 分析早期诊断对治疗资格的影响.
主要成果:
- 由于罕见和多样化的症状,特别是女性,法布里病经常被误诊.
- 心声图和MRI对于识别早期心脏参与 (法布里心肌病) 是至关重要的.
- 早期识别末端器官损伤使得无法接受先进治疗的患者和无症状的家庭成员能够接受治疗.
结论:
- 先进的成像技术对于早期的法布里病诊断和管理至关重要.
- 及时诊断有助于启动治疗,可能改变疾病的进展.
- 查和早期检测对于在受影响家庭中管理法布里病至关重要.
相关概念视频
Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Cardiomyopathy I: Introduction and Classification
514
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514
Cardiomyopathy VI: Nursing Management
314
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
314
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Cardiomyopathy IV: Restrictive Cardiomyopathy
461
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
461


